test44
https://www.cytel.com/blog/bayesian-approach-to-benefit-risk-assessment
July 21, 2021
Conducting a transparent, targeted and robust benefit-risk assessment of a new drug or product is one of the most..
Read article
test44
https://www.cytel.com/blog/hybrid-bayesian-and-frequentist-clinical-trial-designs
March 2, 2021
Most people know that clinical drug discovery is usually conducted using either Frequentist or Bayesian methods. These..
Read article
test44
https://www.cytel.com/blog/webinar-a-clinicians-perspective-on-cancer-drugs-development
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..
Read article
test44
https://www.cytel.com/blog/a-clinicians-perspective-on-cancer-drugs-development-an-interview-with-martin-fey
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..
Read article
test44
https://www.cytel.com/blog/bayesian-benefit-risk-assessment-publication-interview
May 30, 2017
A recent paper The case for Bayesian methods in benefit-risk assessment: Overview and future directions..
Read article
